Fujian Wanchen Biotechnology Group: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the ownership of the first vesting period of the 2023 Restricted Stock Incentive Plan of Fujian Wanchen Biotechnology Group Co., Ltd.

SZSI · May 29

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

万辰集团：上海信公轶禾企业管理咨询有限公司关于福建万辰生物科技集团股份有限公司2023年限制性股票激励计划第一个归属期归属相关事项之独立财务顾问报告

Fujian Wanchen Biotechnology Group: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the ownership of the first vesting period of the 2023 Restricted Stock Incentive Plan of Fujian Wanchen Biotechnology Group Co., Ltd.

Risk Disclaimer

Statement